BIORA THERAPEUTNEW (Germany) Performance

4ZU0 Stock   5.10  0.00  0.00%   
BIORA THERAPEUTNEW holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 95.0, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BIORA THERAPEUTNEW will likely underperform. Use BIORA THERAPEUTNEW coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the information ratio and total risk alpha , to analyze future returns on BIORA THERAPEUTNEW.

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in BIORA THERAPEUTNEW 001 are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BIORA THERAPEUTNEW reported solid returns over the last few months and may actually be approaching a breakup point. ...more
  

BIORA THERAPEUTNEW Relative Risk vs. Return Landscape

If you would invest  4.36  in BIORA THERAPEUTNEW 001 on September 28, 2024 and sell it today you would earn a total of  505.64  from holding BIORA THERAPEUTNEW 001 or generate 11597.25% return on investment over 90 days. BIORA THERAPEUTNEW 001 is generating 17.534% of daily returns assuming 131.2849% volatility of returns over the 90 days investment horizon. Simply put, majority of traded equity instruments are less risky than BIORA on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon BIORA THERAPEUTNEW is expected to generate 162.3 times more return on investment than the market. However, the company is 162.3 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.05 per unit of risk.

BIORA THERAPEUTNEW Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for BIORA THERAPEUTNEW's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIORA THERAPEUTNEW 001, and traders can use it to determine the average amount a BIORA THERAPEUTNEW's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1336

Best PortfolioBest Equity4ZU0
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 131.28
  actual daily
96
96% of assets are less volatile

Expected Return

 5.01
  actual daily
96
96% of assets have lower returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average BIORA THERAPEUTNEW is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIORA THERAPEUTNEW by adding it to a well-diversified portfolio.

About BIORA THERAPEUTNEW Performance

By analyzing BIORA THERAPEUTNEW's fundamental ratios, stakeholders can gain valuable insights into BIORA THERAPEUTNEW's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIORA THERAPEUTNEW has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIORA THERAPEUTNEW has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about BIORA THERAPEUTNEW 001 performance evaluation

Checking the ongoing alerts about BIORA THERAPEUTNEW for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIORA THERAPEUTNEW 001 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BIORA THERAPEUTNEW is not yet fully synchronised with the market data
BIORA THERAPEUTNEW is way too risky over 90 days horizon
BIORA THERAPEUTNEW appears to be risky and price may revert if volatility continues
Evaluating BIORA THERAPEUTNEW's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BIORA THERAPEUTNEW's stock performance include:
  • Analyzing BIORA THERAPEUTNEW's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIORA THERAPEUTNEW's stock is overvalued or undervalued compared to its peers.
  • Examining BIORA THERAPEUTNEW's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating BIORA THERAPEUTNEW's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIORA THERAPEUTNEW's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of BIORA THERAPEUTNEW's stock. These opinions can provide insight into BIORA THERAPEUTNEW's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating BIORA THERAPEUTNEW's stock performance is not an exact science, and many factors can impact BIORA THERAPEUTNEW's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for BIORA Stock analysis

When running BIORA THERAPEUTNEW's price analysis, check to measure BIORA THERAPEUTNEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIORA THERAPEUTNEW is operating at the current time. Most of BIORA THERAPEUTNEW's value examination focuses on studying past and present price action to predict the probability of BIORA THERAPEUTNEW's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIORA THERAPEUTNEW's price. Additionally, you may evaluate how the addition of BIORA THERAPEUTNEW to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance